Higher risk of hepatotoxicity associated with cabozantinib in cancer patients
Release Time:2024-09-03 Hits:
Indexed by: Journal Papers
Document Code: 386900
Date of Publication: 2024-04-18
Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume: 196
ISSN: 1040-8428
Key Words: ACUTE HEPATITIS; KINASE INHIBITORS; MANAGEMENT; OPEN-LABEL; ORAL MEDICATIONS; PLUS CABOZANTINIB; REACTIVE METABOLITES; RENAL-CELL CARCINOMA; SORAFENIB; SUNITINIB